Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial

Journal Title: Global Journal of Allergy - Year 2018, Vol 4, Issue 1

Abstract

Purpose: Allergic rhinitis (AR) affects ~20% of the population worldwide. The objectives of this study were to evaluate the safety and efficacy of iodixanol nasal solution (Nasapaque) for AR treatment, using the Allergen BioCube®, an environmental exposure unit. Iodixanol is a commonly used contrast media agent that shows efficacy on the signs and symptoms of AR.

Authors and Affiliations

pj Gomes, MB Abelson, L Stein, E Viirre, JE Villafranca, EC Lasser

Keywords

Related Articles

Atopic Eczema - From Epidemiology to Therapeutic Approach

Atopic dermatitis is one of the epidemically expanding non-infectious diseases in the 21 century. It poses immense challenges to both patients and physicians. With a steady growth in its incidence and prevalence, the dis...

Dietary or Supplementary Intake Modulates Inflammatory Response in Asthma

The importance of diet and supplement intake in the onset and development of asthma has been advocated recently, and it may be important in the prevention and management of bronchial asthma. Long-chain n-3 polyunsaturate...

Recent Topics in Steroid and Asthma: Beyond the ‘Classic’ Concept of Action

Glucocorticoid (GC)s exert anti-inflammatory effects via binding to the glucocorticoid receptor (GR) (NR3C1), targeted gene expression, and protein synthesis, which need hours before the onset of the action (transactivat...

Impact of Food Allergies on the Allergic Person’s Travel Decision, Trip Organization and Stay Abroad

This survey evaluated the impact of food allergy on the allergic person’s travel decision, trip organization and stay abroad. Hundred and two persons have participated. Results show that food allergy prevents 14% of resp...

Plastic Bronchitis: A Case Report

Plastic bronchitis is a rare disease characterized by the formation of bronchial casts that can cause partial or complete obstruction of the airway. In this case report, a patient aged four years, previously healthy, beg...

Download PDF file
  • EP ID EP533551
  • DOI 10.17352/2455-8141.000021
  • Views 53
  • Downloads 0

How To Cite

pj Gomes, MB Abelson, L Stein, E Viirre, JE Villafranca, EC Lasser (2018). Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial. Global Journal of Allergy, 4(1), 1-8. https://europub.co.uk/articles/-A-533551